Lymphosarcoma  >>  Cytovene (ganciclovir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cytovene (ganciclovir) / Roche
NCT00917826: Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

Terminated
2
1
US
Arginine Butyrate, HQK-1004, Ganciclovir, Valganciclovir
HemaQuest Pharmaceuticals Inc., Boston University
EBV Lymphomas, Lympho-proliferative Diseases
09/09
 

Download Options